Our current results suggest that radiosensitization with the combined HDAC inhibition and RT can increase the expression of NKG2D ligands both in vitro and in vivo in our HCC models and consequently enhance the susceptibility of tumor cells to NK cell-mediated cytotoxicity. The gene discussed is HDAC9; the disease is hepatocellular carcinoma.